Minerva Neurosciences Files 2024 10-K
Ticker: NERV · Form: 10-K · Filed: Feb 25, 2025 · CIK: 1598646
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Minerva Neuro Neurosciences filed its 2024 10-K. All systems go for pharma prep.
AI Summary
Minerva Neurosciences, Inc. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is incorporated in Delaware and headquartered in Waltham, MA. Key financial data and operational details for 2024 are presented, including information on stock options, warrants, and drug product material expenses.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Minerva Neurosciences' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Minerva Neurosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K filing.)
- 1231 — Fiscal Year End (Indicates the end of the reporting period.)
- 2025-02-25 — Filing Date (Date the 10-K was submitted to the SEC.)
Key Players & Entities
- Minerva Neurosciences, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-25 (date) — Filing date
- Waltham, MA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Minerva Neurosciences, Inc.?
Minerva Neurosciences, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When did Minerva Neurosciences, Inc. file its 10-K report?
The 10-K report was filed on February 25, 2025.
What is the fiscal year end for Minerva Neurosciences, Inc.?
The fiscal year end for Minerva Neurosciences, Inc. is December 31 (1231).
Where is Minerva Neurosciences, Inc. headquartered?
Minerva Neurosciences, Inc. is headquartered in Waltham, MA.
What is the SEC file number for Minerva Neurosciences, Inc.?
The SEC file number for Minerva Neurosciences, Inc. is 001-36517.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding Minerva Neurosciences, Inc. (NERV).